GLIOBLASTOMA, IDH-WILDTYPE

Clinical trials for GLIOBLASTOMA, IDH-WILDTYPE explained in plain language.

Never miss a new study

Get alerted when new GLIOBLASTOMA, IDH-WILDTYPE trials appear

Sign up with your email to follow new studies for GLIOBLASTOMA, IDH-WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 2 Not yet finished but already full! 4 Completed 1 Terminated 1

Experimental pill aims to supercharge radiation against deadly brain tumors

Disease control Terminated

This study tested whether adding an oral medication called ropidoxuridine to standard radiation treatment could better control an aggressive type of brain cancer called glioblastoma. The trial involved 30 adults with newly diagnosed tumors that are typically resistant to standard…

Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE

Phase: PHASE2 • Sponsor: Shuttle Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

GLIOBLASTOMA, IDH-WILDTYPE

Get alerted when new GLIOBLASTOMA, IDH-WILDTYPE trials appear

Experimental pill aims to supercharge radiation against deadly brain tumors